Home > Healthcare > Medical Devices > Implantable Devices > Neurovascular Embolization Market
Neurovascular Embolization Market Size
- Report ID: GMI7160
- Published Date: Oct 2023
- Report Format: PDF
Neurovascular Embolization Market Size
Neurovascular Embolization Market size was valued at USD 1.4 billion in 2022 and is estimated to account for USD 2.5 billion by 2032. Neurovascular embolization is a minimally invasive procedure that uses embolic agents delivered through a catheter to treat aneurysms, arteriovenous malformations, and tumors in brain and spinal cord by blocking or reducing blood flow to the affected area.
According to the Brain Aneurysms Foundation, in the U.S., roughly 6.7 million people have unruptured brain aneurysms, leading to an annual rupture rate of 8-10 cases per 100,000. Therefore, the rising prevalence of neurovascular diseases highlights the significance of neurovascular embolization as a crucial treatment, making it a key driver for the market progress.
Furthermore, research efforts dedicated to understanding neurovascular diseases and improving treatment techniques have led to the development of novel therapies. This includes new embolic agents, better imaging modalities, and alternative approaches, expanding the range of options available for physicians. Therefore, research initiatives stimulate market growth by providing new and better solutions.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Neurovascular Embolization Market Size in 2022: | USD 1.4 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 6.4 % |
| 2032 Value Projection: | USD 2.5 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 207 |
| Tables, Charts & Figures: | 287 |
| Segments covered: | Product, Procedure, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Neurovascular Embolization Market Scope
